| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-06 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.24 | 8e-05 |